Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong
· Delayed Price · Currency is HKD 9.96
+0.21 (2.15%)
Aug 14, 2025, 3:45 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 17.59 billion as of August 13, 2025. Its market cap has increased by 251.02% in one year.
Market Cap
17.59B
Enterprise Value
17.97B
Revenue
391.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.96
Market Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has increased from 11.84B to 17.59B, an increase of 48.57%. That is a compound annual growth rate of 12.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 17.59B | 292.55% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 250.26B |
| Hansoh Pharmaceutical Group Company | 214.64B |
| JD Health International | 172.49B |
| Innovent Biologics | 149.52B |
| Akeso | 140.47B |
| Sino Biopharmaceutical | 133.96B |
| WuXi Biologics | 120.32B |
| CSPC Pharmaceutical Group | 114.79B |